Single State Agencies

Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1)…

Mechcatie, Elizabeth. Family Practice News 32(22): 7. November 15, 2002 The approval of the partial opioid agonist buprenorphine for treating opiate dependence has paved the way for office-based treatment of opioid addiction and far greater access to treatment for hundreds of thousands of heroin addicts across the country. Two sublingual formulations have been approved: Buprenorphine…

Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…

Charleston Daily Mail Tuesday February 17, 2004. Boone County man speaks out, officials defend At first, it all seemed so perfectly legal and innocent. A naive Travis Barker swallowed what he thought was a harmless prescription pill, just 20 mg of a popular painkiller called OxyContin. He was told that day about four years ago…

National Alliance for Medication Assisted Recovery (NAMA Recovery) 435 Second Avenue New York, NY 10010 Phone/Fax: (212) 595-NAMA/6262 For More Information Contact:    The President’s Office Directory of Affiliates and Chapters

Letter to Linda Martz, January 6, 2005 Abusers Are Not Who You Think Linda Martz News-Journal (Mansfield, OH) Tue, 07 Dec 2004 MANSFIELD — Those tracking drug trends “expected” to see a spike in deaths from Methadone within Ohio over the past year, the top official at Ohio’s State Board of Pharmacy says. But the…